PMID- 29487347 OWN - NLM STAT- MEDLINE DCOM- 20190923 LR - 20240315 IS - 2045-2322 (Electronic) IS - 2045-2322 (Linking) VI - 8 IP - 1 DP - 2018 Feb 27 TI - Xiexin Tang improves the symptom of type 2 diabetic rats by modulation of the gut microbiota. PG - 3685 LID - 10.1038/s41598-018-22094-2 [doi] LID - 3685 AB - Type 2 diabetes mellitus (T2DM), a chronic metabolic disease which severely impairs peoples' quality of life, currently attracted worldwide concerns. There are growing evidences that gut microbiota can exert a great impact on the development of T2DM. Xiexin Tang (XXT), a traditional Chinese medicine prescription, has been clinically used to treat diabetes for thousands of years. However, few researches are investigated on the modulation of gut microbiota community by XXT which will be very helpful to unravel how it works. In this study, bacterial communities were analyzed based on high-throughput 16S rRNA gene sequencing. Results indicated that XXT could notably shape the gut microbiota. T2DM rats treated with XXT exhibited obvious changes in the composition of the gut microbiota, especially for some short chain fatty acids producing and anti-inflammatory bacteria such as Adlercreutzia, Alloprevotella, Barnesiella, [Eubacterium] Ventriosum group, Blautia, Lachnospiraceae UCG-001, Papillibacter and Prevotellaceae NK3B31 group. Additionally, XXT could also significantly ameliorate hyperglycemia, lipid metabolism dysfunction and inflammation in T2DM rats. Moreover, the correlation analysis illustrated that the key microbiota had a close relationship with the T2DM related indexes. The results probably provided useful information for further investigation on its active mechanism and clinical application. FAU - Wei, Xiaoyan AU - Wei X AD - Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Nanjing University of Chinese Medicine, 138 Xianlin Road, Nanjing, 210023, PR China. FAU - Tao, Jinhua AU - Tao J AUID- ORCID: 0000-0002-7221-3107 AD - Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Nanjing University of Chinese Medicine, 138 Xianlin Road, Nanjing, 210023, PR China. FAU - Xiao, Suwei AU - Xiao S AD - Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Nanjing University of Chinese Medicine, 138 Xianlin Road, Nanjing, 210023, PR China. FAU - Jiang, Shu AU - Jiang S AD - Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Nanjing University of Chinese Medicine, 138 Xianlin Road, Nanjing, 210023, PR China. jiangshu2020@126.com. FAU - Shang, Erxin AU - Shang E AD - Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Nanjing University of Chinese Medicine, 138 Xianlin Road, Nanjing, 210023, PR China. FAU - Zhu, Zhenhua AU - Zhu Z AD - Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Nanjing University of Chinese Medicine, 138 Xianlin Road, Nanjing, 210023, PR China. FAU - Qian, Dawei AU - Qian D AUID- ORCID: 0000-0002-0402-9551 AD - Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Nanjing University of Chinese Medicine, 138 Xianlin Road, Nanjing, 210023, PR China. FAU - Duan, Jinao AU - Duan J AUID- ORCID: 0000-0002-2066-327X AD - Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Nanjing University of Chinese Medicine, 138 Xianlin Road, Nanjing, 210023, PR China. dja@njutcm.edu.cn. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20180227 PL - England TA - Sci Rep JT - Scientific reports JID - 101563288 RN - 0 (Drugs, Chinese Herbal) RN - 0 (Fatty Acids) SB - IM MH - Animals MH - Diabetes Mellitus, Type 2/*drug therapy/*microbiology MH - Drugs, Chinese Herbal/*therapeutic use MH - Fatty Acids/metabolism MH - Gastrointestinal Microbiome/*drug effects MH - Male MH - Medicine, Chinese Traditional MH - Rats MH - Rats, Sprague-Dawley PMC - PMC5829262 COIS- The authors declare no competing interests. EDAT- 2018/03/01 06:00 MHDA- 2019/09/24 06:00 PMCR- 2018/02/27 CRDT- 2018/03/01 06:00 PHST- 2017/08/30 00:00 [received] PHST- 2018/02/13 00:00 [accepted] PHST- 2018/03/01 06:00 [entrez] PHST- 2018/03/01 06:00 [pubmed] PHST- 2019/09/24 06:00 [medline] PHST- 2018/02/27 00:00 [pmc-release] AID - 10.1038/s41598-018-22094-2 [pii] AID - 22094 [pii] AID - 10.1038/s41598-018-22094-2 [doi] PST - epublish SO - Sci Rep. 2018 Feb 27;8(1):3685. doi: 10.1038/s41598-018-22094-2.